Colección SciELO Chile

Departamento Gestión de Conocimiento, Monitoreo y Prospección
Consultas o comentarios: productividad@anid.cl
Búsqueda Publicación
Búsqueda por Tema Título, Abstract y Keywords



APOBEC3G rescues cells from the deleterious effects of DNA damage
Indexado
WoS WOS:000659997900001
Scopus SCOPUS_ID:85107576239
DOI 10.1111/FEBS.16025
Año 2021
Tipo artículo de investigación

Citas Totales

Autores Afiliación Chile

Instituciones Chile

% Participación
Internacional

Autores
Afiliación Extranjera

Instituciones
Extranjeras


Abstract



Human apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G (hA3G), a member of the APOBEC family, was described as an anti-HIV-1 restriction factor, deaminating reverse transcripts of the HIV-1 genome. Several types of cancer cells that express high levels of A3G, such as diffuse large B-cell lymphoma cells and glioblastomas, show enhanced cell survival after ionizing radiation and chemotherapy treatments. Previously, we showed that hA3G promotes (DNA) double-strand breaks repair in cultured cells and rescues transgenic mice from a lethal dose of ionizing radiation. Here, we show that A3G rescues cells from the detrimental effects of DNA damage induced by ultraviolet irradiation and by combined bromodeoxyuridine and ultraviolet treatments. The combined treatments stimulate the synthesis of cellular proteins, which are exclusively associated with A3G expression. These proteins participate mainly in nucleotide excision repair and homologous recombination DNA repair pathways. Our results implicate A3G inhibition as a potential strategy for increasing tumor cell sensitivity to genotoxic treatments.

Revista



Revista ISSN
Febs #Journal 1742-464X

Métricas Externas



PlumX Altmetric Dimensions

Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:

Disciplinas de Investigación



WOS
Biochemistry & Molecular Biology
Scopus
Sin Disciplinas
SciELO
Sin Disciplinas

Muestra la distribución de disciplinas para esta publicación.

Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.

Colaboración Institucional



Muestra la distribución de colaboración, tanto nacional como extranjera, generada en esta publicación.


Autores - Afiliación



Ord. Autor Género Institución - País
1 Botvinnik, Alexander Hombre Hebrew Univ Hadassah Med Sch - Israel
Hebrew University-Hadassah Medical School - Israel
Hebrew University of Jerusalem - Israel
2 Shivam, Pushkar - Hebrew Univ Hadassah Med Sch - Israel
Hebrew University-Hadassah Medical School - Israel
Hebrew University of Jerusalem - Israel
3 Smith, Yoav Hombre Hebrew Univ Jerusalem - Israel
Hebrew University of Jerusalem - Israel
4 Sharma, Gunjan Mujer Hebrew Univ Hadassah Med Sch - Israel
Hebrew University-Hadassah Medical School - Israel
Hebrew University of Jerusalem - Israel
5 Olshevsky, Udy - Hebrew Univ Hadassah Med Sch - Israel
Hebrew University-Hadassah Medical School - Israel
Hebrew University of Jerusalem - Israel
6 Moshel, Ofra Mujer Hebrew Univ Hadassah Med Sch - Israel
Faculty of Medicine - Israel
Hebrew University of Jerusalem - Israel
7 Manevitch, Zakhariya - Hebrew Univ Jerusalem - Israel
Hebrew University of Jerusalem - Israel
8 Climent, Nuria Mujer Univ Barcelona - España
Universitat de Barcelona, Facultad de Medicina y Ciencias de la Salud - España
9 Oliva, H. Hombre Veterquimica SA - Chile
Veterquímica S.A. - Chile
10 Britan-Rosich, Elena Mujer Hebrew Univ Hadassah Med Sch - Israel
Hebrew University-Hadassah Medical School - Israel
Hebrew University of Jerusalem - Israel
11 Kotler, Moshe Hombre Hebrew Univ Hadassah Med Sch - Israel
Hebrew University-Hadassah Medical School - Israel
Hebrew University of Jerusalem - Israel

Muestra la afiliación y género (detectado) para los co-autores de la publicación.

Financiamiento



Fuente
Canadian Institutes of Health Research
Israel Science Foundation (ISF)
Canadian Institutes of Health Research (CIHR)
Israel Science Foundation
International Development Research Centre
International Development Research Centre (IDRC)
Israel Cancer Foundation

Muestra la fuente de financiamiento declarada en la publicación.

Agradecimientos



Agradecimiento
We thank Dr R. S. Harris for his generous gift of SupT11A3G and Sup T11EV cells and Dr Michael Berger and Dr Sheera Adar for valuable discussion and critical reading of the manuscript. This research (grant No. 2665/16 MK) was carried out with the aid of a grant from the Canadian Institutes of Health Research (CIHR), the International Development Research Centre (IDRC), the Israel Science Foundation (ISF) and the Israel Cancer Foundation (20200084 MK).
We thank Dr R. S. Harris for his generous gift of SupT11 and Sup T11 cells and Dr Michael Berger and Dr Sheera Adar for valuable discussion and critical reading of the manuscript. This research (grant No. 2665/16 MK) was carried out with the aid of a grant from the Canadian Institutes of Health Research (CIHR), the International Development Research Centre (IDRC), the Israel Science Foundation (ISF) and the Israel Cancer Foundation (20200084 MK). A3G EV

Muestra la fuente de financiamiento declarada en la publicación.